Your browser doesn't support javascript.
loading
Outcome after resection for perihilar cholangiocarcinoma in patients with primary sclerosing cholangitis: an international multicentre study.
Jansson, Hannes; Olthof, Pim B; Bergquist, Annika; Ligthart, Marjolein A P; Nadalin, Silvio; Troisi, Roberto I; Groot Koerkamp, Bas; Alikhanov, Ruslan; Lang, Hauke; Guglielmi, Alfredo; Cescon, Matteo; Jarnagin, William R; Aldrighetti, Luca; van Gulik, Thomas M; Sparrelid, Ernesto.
Afiliação
  • Jansson H; Division of Surgery, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. Electronic address: hannes.jansson@ki.se.
  • Olthof PB; Department of Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • Bergquist A; Unit of Gastroenterology and Rheumatology, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
  • Ligthart MAP; Department of Surgery, Maastricht University Medical Center, Maastricht, the Netherlands.
  • Nadalin S; Department of General and Transplant Surgery, University Hospital Tübingen, Tübingen, Germany.
  • Troisi RI; Department of Human Structure and Repair, Faculty of Medicine, Ghent University, Ghent, Belgium; Department of Clinical Medicine and Surgery, Division of HBP, Minimally Invasive and Robotic Surgery, Federico II University Naples, Naples, Italy.
  • Groot Koerkamp B; Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Alikhanov R; Department of Hepato-Pancreato-Biliary Surgery, Moscow Clinical Scientific Center, Moscow, Russia.
  • Lang H; Department of General, Visceral and Transplantation Surgery, University Hospital of Mainz, Mainz, Germany.
  • Guglielmi A; Department of Surgery, Unit of Hepato-Pancreato-Biliary Surgery, University of Verona Medical School, Verona, Italy.
  • Cescon M; General Surgery and Transplantation Unit, Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Jarnagin WR; Division of Hepatopancreatobiliary Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
  • Aldrighetti L; Hepato-biliary Surgery Division, Ospedale San Raffaele-IRCCS, Milan, Italy.
  • van Gulik TM; Department of Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • Sparrelid E; Division of Surgery, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
HPB (Oxford) ; 23(11): 1751-1758, 2021 11.
Article em En | MEDLINE | ID: mdl-33975797
ABSTRACT

BACKGROUND:

Resection for perihilar cholangiocarcinoma (pCCA) in primary sclerosing cholangitis (PSC) has been reported to lead to worse outcomes than resection for non-PSC pCCA. The aim of this study was to compare prognostic factors and outcomes after resection in patients with PSC-associated pCCA and non-PSC pCCA.

METHODS:

The international retrospective cohort comprised patients resected for pCCA from 21 centres (2000-2020). Patients operated with hepatobiliary resection, with pCCA verified by histology and with data on PSC status, were included. The primary outcome was overall survival. Secondary outcomes were disease-free survival and postoperative complications.

RESULTS:

Of 1128 pCCA patients, 34 (3.0%) had underlying PSC. Median overall survival after resection was 33 months for PSC patients and 29 months for non-PSC patients (p = .630). Complications (Clavien-Dindo grade ≥ 3) were more frequent in PSC pCCA (71% versus 44%, p = .003). The rate of posthepatectomy liver failure (21% versus 17%, p = .530) and 90-day mortality (12% versus 13%, p = 1.000) was similar for PSC and non-PSC patients.

CONCLUSION:

Median overall survival after resection for pCCA was similar in patients with underlying PSC and non-PSC patients. Complications were more frequent after resection for PSC-associated pCCA, with no difference in postoperative mortality.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias dos Ductos Biliares / Colangite Esclerosante / Tumor de Klatskin / Colangiocarcinoma Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: HPB (Oxford) Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias dos Ductos Biliares / Colangite Esclerosante / Tumor de Klatskin / Colangiocarcinoma Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: HPB (Oxford) Ano de publicação: 2021 Tipo de documento: Article